| 1 |
Xie R, Chen W, Lv Y, Xu D, Huang D, Zhou T, Zhang S, Xiong C, Yu J. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation. J Formos Med Assoc 2023:S0929-6646(22)00477-6. [PMID: 36739231 DOI: 10.1016/j.jfma.2022.12.019] [Reference Citation Analysis]
|
| 2 |
Kang J, Xiang X, Chen X, Jiang J, Zhang Y, Li L, Tang J. Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. Front Cell Dev Biol 2022;10:1086835. [PMID: 36712973 DOI: 10.3389/fcell.2022.1086835] [Reference Citation Analysis]
|
| 3 |
Fang F, Wang P, Huang H, Ye M, Liu X, Li Q. m(6)A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinoma. BMC Cancer 2022;22:1364. [PMID: 36581816 DOI: 10.1186/s12885-022-10490-x] [Reference Citation Analysis]
|
| 4 |
Huang G, Huang S, Cui H. Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis. Front Pharmacol 2022;13:993567. [PMID: 36518679 DOI: 10.3389/fphar.2022.993567] [Reference Citation Analysis]
|
| 5 |
Kong F, Wang K, Wang L. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma. Discov Oncol 2022;13:131. [PMID: 36434140 DOI: 10.1007/s12672-022-00595-x] [Reference Citation Analysis]
|
| 6 |
Wang Z, Zhou J, Zhang H, Ge L, Li J, Wang H. RNA m(6) A methylation in cancer. Mol Oncol 2023;17:195-229. [PMID: 36260366 DOI: 10.1002/1878-0261.13326] [Reference Citation Analysis]
|
| 7 |
Yang Y, Qian Z, Feng M, Liao W, Wu Q, Wen F, Li Q. Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancer. BMC Bioinformatics 2022;23:437. [PMID: 36261786 DOI: 10.1186/s12859-022-04984-5] [Reference Citation Analysis]
|
| 8 |
Shen C, Chen Z, Jiang J, Zhang Y, Xu W, Peng R, Zuo W, Jiang Q, Fan Y, Fang X, Zheng B. A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients. Front Genet 2022;13:1034567. [DOI: 10.3389/fgene.2022.1034567] [Reference Citation Analysis]
|
| 9 |
Liu S, Chen S, Tang C, Zhao Y, Cui W, Jia L, Wang L. The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development. Front Oncol 2022;12:970833. [DOI: 10.3389/fonc.2022.970833] [Reference Citation Analysis]
|
| 10 |
Ding D, Liu G, Gao J, Cao M, Li S. Unveiling the m6A Methylation Regulator Links between Prostate Cancer and Periodontitis by Transcriptomic Analysis. Disease Markers 2022;2022:1-22. [DOI: 10.1155/2022/4030046] [Reference Citation Analysis]
|
| 11 |
Kong F, Wang K. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.. [DOI: 10.21203/rs.3.rs-1992254/v1] [Reference Citation Analysis]
|
| 12 |
Lin Y, Zhang B, Chen Z. circRERE regulates the expression of GBX2 through miR-1299 and ZC3H13/N6-methyladenosine (m6A) to promote growth and invasion of hepatocellular carcinoma cells. J Biosci 2022;47. [DOI: 10.1007/s12038-022-00298-z] [Reference Citation Analysis]
|
| 13 |
Liu F, Zhang X, Liu Z, Cai W, Song C, Jiang Y, Yin J, Liu Z, Huang C, Bu D. M6A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-25. [DOI: 10.1155/2022/2513813] [Reference Citation Analysis]
|
| 14 |
Fang Z, Mei W, Qu C, Lu J, Shang L, Cao F, Li F. Role of m6A writers, erasers and readers in cancer. Exp Hematol Oncol 2022;11:45. [PMID: 35945641 DOI: 10.1186/s40164-022-00298-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 15 |
Gentile D, Esposito M, Grumati P. Metabolic adaption of cancer cells toward autophagy: Is there a role for ER-phagy? Front Mol Biosci 2022;9:930223. [DOI: 10.3389/fmolb.2022.930223] [Reference Citation Analysis]
|
| 16 |
Jia J, Wu S, Jia Z, Wang C, Ju C, Sheng J, He F, Zhou M, He J. Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance. Int J Biol Sci 2022;18:4432-51. [PMID: 35864970 DOI: 10.7150/ijbs.73093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Qiu Y, Li J, Yao J, Meng J, Huang X, Zheng X, Wen Z, Huang J, Wang H, De Vita A. Correlative Study on the Relationship between the Expression of m6a-Related Genes and the Prognosis and Immunotherapy of Soft Tissue Sarcoma. BioMed Research International 2022;2022:1-35. [DOI: 10.1155/2022/5439023] [Reference Citation Analysis]
|
| 18 |
Xia Z, Kong F, Wang K, Zhang X. Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours. Front Pharmacol 2022;13:908079. [PMID: 35754499 DOI: 10.3389/fphar.2022.908079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
Luo G, Wang S, Ai Y, Li J, Ren Z. N6-Methyladenosine Methylome Profiling of Muscle and Adipose Tissues Reveals Methylase-mRNA Metabolic Regulatory Networks in Fat Deposition of Rex Rabbits. Biology (Basel) 2022;11. [PMID: 36101325 DOI: 10.3390/biology11070944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Luparello C, Branni R, Abruscato G, Lazzara V, Drahos L, Arizza V, Mauro M, Di Stefano V, Vazzana M. Cytotoxic capability and the associated proteomic profile of cell-free coelomic fluid extracts from the edible sea cucumber Holothuria tubulosa on HepG2 liver cancer cells. EXCLI J 2022;21:722-43. [PMID: 35721581 DOI: 10.17179/excli2022-4825] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Wu Z, Yin B, You F. Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts. Front Pharmacol 2022;13:820474. [PMID: 35721163 DOI: 10.3389/fphar.2022.820474] [Reference Citation Analysis]
|
| 22 |
Ram AK, Vairappan B. Role of zonula occludens in gastrointestinal and liver cancers. World J Clin Cases 2022; 10(12): 3647-3661 [DOI: 10.12998/wjcc.v10.i12.3647] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Xiao K, Yang Z, Yan X, Liu Z, Yang M, Guo L, Cai L. Molecular Characteristics of m6A Regulators and Tumor Microenvironment Infiltration in Soft Tissue Sarcoma: A Gene-Based Study. Front Bioeng Biotechnol 2022;10:846812. [DOI: 10.3389/fbioe.2022.846812] [Reference Citation Analysis]
|
| 24 |
Hasan A, Rizvi SF, Parveen S, Pathak N, Nazir A, Mir SS. Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox. Front Oncol 2022;12:852424. [PMID: 35359388 DOI: 10.3389/fonc.2022.852424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Gu Z, Du Y, Zhao X, Wang C. Diagnostic, Therapeutic, and Prognostic Value of the m6A Writer Complex in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:822011. [PMID: 35223847 DOI: 10.3389/fcell.2022.822011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Lu M, Li J, Fan X, Xie F, Fan J, Xiong Y. Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network. Front Genet 2022;13:829384. [DOI: 10.3389/fgene.2022.829384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
Miao Y, Su B, Tang X, Wang J, Quan W, Chen Y, Mi D. Construction and validation of m6 A RNA methylation regulators associated prognostic model for gastrointestinal cancer. IET Syst Biol 2022. [PMID: 35174637 DOI: 10.1049/syb2.12040] [Reference Citation Analysis]
|
| 28 |
Huang W, Kong F, Li R, Chen X, Wang K. Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer. Front Oncol 2022;12:827956. [PMID: 35155260 DOI: 10.3389/fonc.2022.827956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 29 |
Yao L, Man CF, He R, He L, Huang JB, Xiang SY, Dai Z, Wang XY, Fan Y. The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers. Front Oncol 2021;11:784127. [PMID: 35070987 DOI: 10.3389/fonc.2021.784127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Huang C, Zhou S, Zhang C, Jin Y, Xu G, Zhou L, Ding G, Pang T, Jia S, Cao L. ZC3H13-mediated N6-methyladenosine modification of PHF10 is impaired by fisetin which inhibits the DNA damage response in pancreatic cancer. Cancer Lett 2022:S0304-3835(22)00021-0. [PMID: 35033590 DOI: 10.1016/j.canlet.2022.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 31 |
Wang Q, Xie H, Peng H, Yan J, Han L, Ye G. ZC3H13 Inhibits the Progression of Hepatocellular Carcinoma through m6A-PKM2-Mediated Glycolysis and Enhances Chemosensitivity. J Oncol 2021;2021:1328444. [PMID: 35003256 DOI: 10.1155/2021/1328444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Liu R, Shen Y, Hu J, Wang X, Wu D, Zhai M, Bai J, He A. Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma. Front Oncol 2021;11:731957. [PMID: 34804925 DOI: 10.3389/fonc.2021.731957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 33 |
Deng M, Fang L, Li SH, Zhao RC, Mei J, Zou JW, Wei W, Guo RP. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma. Mutagenesis 2021;36:369-79. [PMID: 34467992 DOI: 10.1093/mutage/geab032] [Reference Citation Analysis]
|
| 34 |
Liu Z, Zhong J, Zeng J, Duan X, Lu J, Sun X, Liu Q, Liang Y, Lin Z, Zhong W, Wu W, Cai C, Zeng G. Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy. Front Immunol 2021;12:735170. [PMID: 34531875 DOI: 10.3389/fimmu.2021.735170] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 35 |
Guo T, Duan H, Chen J, Liu J, Othmane B, Hu J, Li H, Zu X. N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma. Front Oncol 2021;11:718644. [PMID: 34497769 DOI: 10.3389/fonc.2021.718644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 36 |
Xu Q, Xu H, Deng R, Li N, Mu R, Qi Z, Shen Y, Wang Z, Wen J, Zhao J, Weng D, Huang W. Landscape of Prognostic m6A RNA Methylation Regulators in Hepatocellular Carcinoma to Aid Immunotherapy. Front Cell Dev Biol 2021;9:669145. [PMID: 34422799 DOI: 10.3389/fcell.2021.669145] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Wang Y, Yang F, Shang J, He H, Yang Q. Integrative analysis reveals the prognostic value and functions of splicing factors implicated in hepatocellular carcinoma. Sci Rep 2021;11:15175. [PMID: 34312475 DOI: 10.1038/s41598-021-94701-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Hu Y, Zhao X. Role of m6A in osteoporosis, arthritis and osteosarcoma (Review). Exp Ther Med 2021;22:926. [PMID: 34306195 DOI: 10.3892/etm.2021.10358] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 39 |
Zhang C, Liu J, Guo H, Hong D, Ji J, Zhang Q, Guan Q, Ren Q. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Bioengineered 2021;12:3159-76. [PMID: 34187307 DOI: 10.1080/21655979.2021.1946305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 40 |
Du Y, Ma Y, Zhu Q, Liu T, Jiao Y, Yuan P, Wang X. An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment. Front Pharmacol 2021;12:707930. [PMID: 34248650 DOI: 10.3389/fphar.2021.707930] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Ma J, Yang D, Ma XX. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer. Aging (Albany NY) 2021;13:16287-315. [PMID: 34230220 DOI: 10.18632/aging.203157] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 42 |
Liu GM, Zeng HD, Zhang CY, Xu JW. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma. Dig Dis Sci 2021;66:1110-26. [PMID: 32333311 DOI: 10.1007/s10620-020-06260-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 43 |
Dai B, Sun F, Cai X, Li C, Liu H, Shang Y. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database. Front Genet 2021;12:634162. [PMID: 33763115 DOI: 10.3389/fgene.2021.634162] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 44 |
Kuai D, Zhu S, Shi H, Yang R, Liu T, Liu H, Min L, Zhang S. Aberrant expression of m6A mRNA methylation regulators in colorectal adenoma and adenocarcinoma. Life Sci 2021;273:119258. [PMID: 33636176 DOI: 10.1016/j.lfs.2021.119258] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 45 |
Cong R, Ji C, Zhang J, Zhang Q, Zhou X, Yao L, Luan J, Meng X, Song N. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Transl Androl Urol 2021;10:662-79. [PMID: 33718069 DOI: 10.21037/tau-20-963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 46 |
Bányai L, Trexler M, Kerekes K, Csuka O, Patthy L. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. Elife 2021;10:e59629. [PMID: 33427197 DOI: 10.7554/eLife.59629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 47 |
Huang J, Chen Z, Chen X, Chen J, Cheng Z, Wang Z. The role of RNA N 6-methyladenosine methyltransferase in cancers. Mol Ther Nucleic Acids 2021;23:887-96. [PMID: 33614237 DOI: 10.1016/j.omtn.2020.12.021] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 48 |
Li Y, Li ZX, Xie CY, Fan J, Lv J, Xu XJ, Lv J, Kuai WT, Jia YT. Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota. World J Gastroenterol 2020; 26(48): 7633-7651 [PMID: 33505141 DOI: 10.3748/wjg.v26.i48.7633] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 49 |
Jogalekar MP, Veerabathini A, Gangadaran P. Recent developments in autophagy-targeted therapies in cancer. Exp Biol Med (Maywood) 2021;246:207-12. [PMID: 33167689 DOI: 10.1177/1535370220966545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 50 |
Wang LC, Chen SH, Shen XL, Li DC, Liu HY, Ji YL, Li M, Yu K, Yang H, Chen JJ, Qin CZ, Luo MM, Lin QX, Lv QL. M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme. Front Oncol 2020;10:536875. [PMID: 33134160 DOI: 10.3389/fonc.2020.536875] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 51 |
Wu H, Dong H, Fu Y, Tang Y, Dai M, Chen Y, Wang G, Wu Y. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma. Clin Exp Pharmacol Physiol 2021;48:270-8. [PMID: 33006785 DOI: 10.1111/1440-1681.13412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Zhang L, Qiao Y, Huang J, Wan D, Zhou L, Lin S, Zheng S. Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma. Front Med (Lausanne) 2020;7:556. [PMID: 33072775 DOI: 10.3389/fmed.2020.00556] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 53 |
Pan J, Xu L, Pan H. Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma. Front Oncol 2020;10:1444. [PMID: 32974164 DOI: 10.3389/fonc.2020.01444] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 54 |
Liu W, Zhong C, Lv D, Tang M, Xie F. N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma. Front Genet 2020;11:863. [PMID: 32903675 DOI: 10.3389/fgene.2020.00863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 55 |
Wu X, Zhang X, Tao L, Dai X, Chen P. Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma. Biomed Res Int 2020;2020:2053902. [PMID: 32733931 DOI: 10.1155/2020/2053902] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 56 |
Li G, Qian L, Tang X, Chen Y, Zhao Z, Zhang C. Long non‑coding RNA growth arrest‑specific 5 (GAS5) acts as a tumor suppressor by promoting autophagy in breast cancer. Mol Med Rep 2020;22:2460-8. [PMID: 32705220 DOI: 10.3892/mmr.2020.11334] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 57 |
Xu N, Chen J, He G, Gao L, Zhang D. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma. J Cancer 2020;11:5187-97. [PMID: 32742465 DOI: 10.7150/jca.41193] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 58 |
Yi L, Wu G, Guo L, Zou X, Huang P. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma. Mol Ther Nucleic Acids 2020;21:299-314. [PMID: 32622331 DOI: 10.1016/j.omtn.2020.06.001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 24.3] [Reference Citation Analysis]
|
| 59 |
Zhang QJ, Luan JC, Song LB, Cong R, Ji CJ, Zhou X, Xia JD, Song NH. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma. Exp Cell Res 2020;392:112015. [PMID: 32333907 DOI: 10.1016/j.yexcr.2020.112015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 60 |
Jiang F, Chen Y, Ren S, Li Z, Sun K, Xing Y, Zhu Y, Piao D. Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway. Int J Oncol 2020;57:183-96. [PMID: 32319595 DOI: 10.3892/ijo.2020.5038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 61 |
Zhu S, Wang JZ, Chen, He YT, Meng N, Chen M, Lu RX, Chen XH, Zhang XL, Yan GR. An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis. Nat Commun 2020;11:1685. [PMID: 32245947 DOI: 10.1038/s41467-020-15403-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 74] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 62 |
Wang J, Zhang C, He W, Gou X. Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma. Front Oncol 2020;10:3. [PMID: 32038982 DOI: 10.3389/fonc.2020.00003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 63 |
Mittal S, Kumar G, Parashar D, Geethadevi A, Jadhav K, Balasubramani GL, Cheema PS, Srivastava CM, Tuli HS. Regulatory Roles of Autophagy in Cancer. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models 2020. [DOI: 10.1007/978-981-15-7586-0_5] [Reference Citation Analysis]
|
| 64 |
Jiang L, Zheng J, Kwan JSH, Dai S, Li C, Li MJ, Yu B, To KF, Sham PC, Zhu Y, Li M. WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts. Nucleic Acids Res 2019;47:e96. [PMID: 31287869 DOI: 10.1093/nar/gkz566] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 65 |
Ayers K, Kumar R, Robevska G, Bruell S, Bell K, Malik MA, Bathgate RA, Sinclair A. Familial bilateral cryptorchidism is caused by recessive variants in RXFP2. J Med Genet 2019;56:727-33. [PMID: 31167797 DOI: 10.1136/jmedgenet-2019-106203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 66 |
Yun CW, Lee SH. The Roles of Autophagy in Cancer. Int J Mol Sci. 2018;19. [PMID: 30400561 DOI: 10.3390/ijms19113466] [Cited by in Crossref: 377] [Cited by in F6Publishing: 407] [Article Influence: 75.4] [Reference Citation Analysis]
|
